Monika Joshi, MD, on After the DUART Trial: Next Steps in Treating Urothelial Cancer of the Bladder

Monika Joshi, MD, of Penn State Hershey Cancer Institute, discusses possible next treatment steps in light of findings from the DUART study on concurrent durvalumab and radiation therapy followed by adjuvant durvalumab in patients with localized urothelial cancer of the bladder. Dr. Joshi also offers advice on managing adverse effects to clinicians with little experience using this checkpoint inhibitor.